NLGN4Y and prostate carcinoma: Utilizing in vitro study in prostate cancer cell PC‐3, Gong et al found that the expression of NLGN4Y negatively controlled cell proliferation and decreased cell migration through modifying GTPase activities (Gong et al., 2016).